TerrAscend Acquires Hunterdon County Dispensary in New Jersey

Deal Adds Retail Capacity in Western New Jersey

TerrAscend closed the acquisition of a Hunterdon County dispensary, expanding its New Jersey retail network into a less-saturated market outside the state's urban core. The company didn't disclose the purchase price or the seller's identity. Hunterdon County sits along the Pennsylvania border. Population: roughly 128,000. It's seen fewer dispensary openings than Hudson, Essex, and Bergen counties.

TerrAscend operates The Apothecarium-branded stores across New Jersey, California, and Pennsylvania. The company reported 18 retail locations across its operating footprint in its most recent quarterly filing. New Jersey adult-use sales topped $1.9 billion in the 12 months ending August 2026, according to state Cannabis Regulatory Commission data.

New Jersey Market Dynamics Favor Multi-Store Operators

New Jersey's regulatory framework caps vertical operators at 10 retail licenses statewide, creating consolidation pressure as MSOs race to secure prime locations before the limit binds. TerrAscend holds cultivation, processing, and retail licenses in the state. The Hunterdon acquisition positions the company in a county with lower real-estate costs and less retail density than northern urban markets.

Adult-use sales launched in April 2022. Monthly sales have plateaued near $160 million since mid-2025, reflecting market saturation in high-traffic corridors and slower rollout in suburban and rural zones. Hunterdon County issued its first adult-use retail permits in early 2025, later than most counties. TerrAscend's move suggests a bet on underserved geography as coastal markets mature.

For broader context on TerrAscend's growth strategy across multiple states, see the CannIntel topic hub on TerrAscend Expansion.

What This Means for New Jersey's Retail Landscape

The acquisition signals continued M&A activity among vertically integrated operators seeking to maximize retail footprints before New Jersey's license caps take full effect. Smaller single-location operators face capital and compliance pressures. That makes them acquisition targets for MSOs with treasury depth and existing supply chains.

TerrAscend reported $72 million in cash and $285 million in total debt as of its Q2 2026 earnings. The company has pursued tuck-in retail acquisitions in Pennsylvania and New Jersey over the past 18 months, prioritizing markets where it already operates cultivation and processing infrastructure. Vertical integration reduces reliance on wholesale flower markets and stabilizes margins in price-competitive states.

Watch for additional New Jersey retail deals before TerrAscend hits the 10-store cap. Will rival MSOs Verano, Curaleaf, or Ascend Wellness follow with rural-market acquisitions of their own?